Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
Clinical trial NCT00580216 · TERMINATED
Trial details
- NCT number
- NCT00580216
- Sponsor
- Sanofi
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2010-10-01
- Enrollment
- 3773
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.